Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclic Oral Methylprednisolone in Progressive MS
NCT01305837Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2011
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in multiple sclerosis (MS), sponsored by Rigshospitalet. Started Apr 2011; status: completed.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01305837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305837.